Insider · CIK 0001240801
Douglas Forsyth
Files at INBX (Inhibrx Biosciences, Inc.). First filing Sep 8, 2026, latest Sep 8, 2026.
In brief
Douglas Forsyth files SEC Form 4 as director at INBX (Inhibrx Biosciences, Inc.). Since Sep 8, 2026, Douglas Forsyth has reported 1 open-market buy worth $287k and 0 open-market sells worth $0, the latest filed on Sep 8, 2026.
A track record needs three past buys with six months of prices behind them; Douglas Forsyth has 0, so none is measured yet.
The newest scored trade: bought $287k of INBX on Sep 8, 2026, filed Sep 8, 2026, scored 44 (moderate). In the last 12 months: 1 buy worth $287k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INBX: Inhibrx Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Inhibrx Biosciences, Inc. | $287k 2,500 shares | +1% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | 25 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Forsyth Family Trust Dated July 20, 2001 | +2,500 | $114.65 | $287k | 227,064 | 35 d ago |
| Jun 3, 2026 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 4, 2026 |
| May 28, 2025 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | May 29, 2025 |
Questions about Douglas Forsyth
Answered from the filings on this page, as of the latest one.
Is Douglas Forsyth buying or selling?
In the last 12 months Douglas Forsyth reported 1 open-market buy worth $287k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $287k of INBX on Sep 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Douglas Forsyth's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas Forsyth has 0.
Where does Douglas Forsyth file Form 4?
Douglas Forsyth has filed Form 4 at INBX (Inhibrx Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.